Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA; Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospital, Houston, TX, USA; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Waltham, MA, USA.
Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Waltham, MA, USA.
Am J Hum Genet. 2022 Dec 1;109(12):2105-2109. doi: 10.1016/j.ajhg.2022.10.016.
Synonymous mutations change the DNA sequence of a gene without affecting the amino acid sequence of the encoded protein. Although some synonymous mutations can affect RNA splicing, translational efficiency, and mRNA stability, studies in human genetics, mutagenesis screens, and other experiments and evolutionary analyses have repeatedly shown that most synonymous variants are neutral or only weakly deleterious, with some notable exceptions. Based on a recent study in yeast, there have been claims that synonymous mutations could be as important as nonsynonymous mutations in causing disease, assuming the yeast findings hold up and translate to humans. Here, we argue that there is insufficient evidence to overturn the large, coherent body of knowledge establishing the predominant neutrality of synonymous variants in the human genome.
同义突变改变基因的 DNA 序列而不影响编码蛋白质的氨基酸序列。虽然一些同义突变会影响 RNA 剪接、翻译效率和 mRNA 稳定性,但人类遗传学研究、诱变筛选和其他实验及进化分析反复表明,大多数同义变体是中性或仅具有弱的有害性,也有一些明显的例外。根据最近在酵母中的一项研究,有人声称,同义突变在导致疾病方面可能与非同义突变一样重要,前提是酵母的发现成立并能转化到人类身上。在这里,我们认为,没有足够的证据推翻大量一致的知识体系,该体系确立了人类基因组中同义变体的主要中性地位。